Avant Diagnostics, Inc. Corporate Update
May 08, 2019 15:28 ET
|
Avant Diagnostics, Inc.
Washington, DC, May 08, 2019 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. hereby provides the following corporate update to the Company’s shareholders. A copy of the update can also be found on the...
AVANT DIAGNOSTICS COMMENTS ON HALT OF TRADING OF COMMON STOCK
September 24, 2018 09:38 ET
|
Avant Diagnostics, Inc.
Washington, DC, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. ("Avant" or the “Company”) (OTC Pink: AVDX), announced today that trading in its common stock has been temporarily...
Avant Diagnostics Presented Data on TheraLink® Pancreatic Cancer Assay at the International Symposium on Pancreas Cancer 2016
June 14, 2016 09:00 ET
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz. and GAITHERSBERG, Md., June 14, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (“Avant”) (OTCQB:AVDX), an innovative molecular diagnostics company, today announced that Dr. Vince...
Avant Diagnostics to Present at Upcoming Investor Conferences
May 31, 2016 09:00 ET
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz. and GAITHERSBERG, Md., May 31, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (“Avant”) (OTCQB:AVDX), an innovative molecular diagnostics company, today announced that Company...
Avant Diagnostics Announces Data Presentations at 2016 ASCO Annual Meeting
May 19, 2016 09:15 ET
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz. and GAITHERSBERG, Md., May 19, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (“Avant”) (OTCQB:AVDX), an innovative molecular diagnostics company, today announced the acceptance...
Avant Diagnostics Simultaneously Completes Acquisitions of Amarantus Diagnostics and Theranostics Health
May 12, 2016 07:30 ET
|
Avant Diagnostics, Inc.
Operations of Amarantus Diagnostics and Theranostics Health have consolidated into Avant Diagnostics (OTCQB:AVDX)Diagnostics pipeline in Alzheimer’s disease (LymPro Test™), Ovarian cancer (OvaDx™) and...
Amarantus Enters into Letter of Intent to Merge Diagnostics Business Unit into Avant Diagnostics
January 19, 2016 09:00 ET
|
Avant Diagnostics, Inc.
SAN FRANCISCO and SCOTTSDALE, Ariz., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing products in Regenerative Medicine,...
Avant Diagnostics to Attend 12th Annual Noble Capital Markets Conference
January 15, 2016 09:00 ET
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCQB:AVDX), "Avant", announces that CEO Gregg Linn will be presenting at the NobleCon12 - Noble Financial Capital...
Avant Diagnostics Inc. Receives FDA IRB Approval for OvaDx(R) Ovarian Cancer Validation Test Specimens
October 07, 2015 08:00 ET
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz., Oct. 07, 2015 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCQB:AVDX) (“Avant”), an innovative in vitro diagnostics company, was notified by DOCRO, its independent clinical...
Avant Diagnostics Inc. Commences OvaDx(R) Ovarian Cancer Test Calibration in Preparation for FDA Submission
September 24, 2015 10:24 ET
|
Avant Diagnostics, Inc.
SCOTTSDALE, Ariz., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCQB:AVDX) ("Avant"), an innovative molecular diagnostics company, began calibration testing in preparation for the...